Acute kidney graft rejection morphology and immunology

APMIS, Supplement

Volumn 105, Issue 67, 1997, Pages 5-35

  Andersen, Claus B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOKINE; DILTIAZEM; PREDNISOLONE;

CELLULAR IMMUNITY; CYTOMEGALOVIRUS; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; IMMUNOLOGY; PATHOLOGY;

ACUTE DISEASE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION;

EID: 0031040912     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1997.tb05595.x     Document Type: Article

References (233)

1. Allen MD,Thomas G, McDonald BS, Himes VE, Fishbein DP, Aciz S & Reichenbach DD. E-selectin expression in human cardiac grafts with cellular rejection. Circulation 88:11-243-11-247, 1993.
2. Alpers CE, Hudkins KL, Davis CL, Marsh L, Riches W, McCarty IM, Benjamin CD, Carlos IM, Harlan JM & Lobb R. Expression of vascular adhesion molecule-1 in kidney allograft rejection. Kid Int 44:805-816, 1993.
3. Anderson KC & Weinstein HJ. Transfusion-associated graft-versus-host disease. New Eng J Med 323:315-321, 1990.
4. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M, Martinelli L, Gavazzi A, Gog-gi C, Campana C & Vigmo M. Expression of tumor necrosis factor in human acute cardiac rejection. Am J Pathol 139:709-715, 1991.
5. Arrizabalaga P, Mirapeix E, Danell A, Andreau J, Oppenheimer F, Gallart T, Torras A & Revert L. Cellular infiltration in renal graft rejection: T lymphocyte subsets detected by monoclonal antibodies. Nephron 44: 11-17, 1986.
6. Ascher NL, Huffman RA, Hanto DW & Simmons RL. Cellular basis of allograft rejection. Immunological Rev. 77:218-232, 1984.
7. August ST,Wolfe EJ, Orentas RJ & Hildreth JEK. Proteins - and the molecular basis of transplantation immunity. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 8-9.
8. Austyn JM & Larsen CP. Migration patterns of dendritic leucocyte: Implications for transplantation. Transplantation 49:1-7, 1990.
9. Axelsen RA, Seymore AE, Mathew TH, Canny A & Pascoe V. Glomerular transplant rejection: A distinctive pattern of early graft damage. Clin Nephrol 23:1-11, 1985.
10. Bach F. Summary: Symposium on lymphocyte activation. Kid Int 38:381-383, 1990.
11. Banfi G, Imbasciati E,Tarantino A & Panticelli C. Prognostic value of renal biopsy in acute rejection of kidney transplantation. Nephron 28:222-226, 1981.
12. Bergstrand A, Bohman SO, Famsworth A, Gokel JM, Krause PH, Lang W, Mihatsch MJ, Oppedal B, Cell S, Sibley RK, Thirou S, Verani R, Wallace AC, Zollinger HU, Ryffel B, Thiel G & Wonigeit K. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporine A: Results of an international workshop. Clin Nephrol 24:107-119, 1985.
13. Berlin PJ, Bacher JD, Sharrow SO, Gonzalez C & Gress RE. Monoclonal antibodies against human T-cell adhesion molecules - modulation of immune function in non-human primates. Transplantation 53: 840-849, 1992.
14. Beschorner WE, Burdick JF, Williams GM & Solez K. The presence of leu-7 reactive lymphocytes in renal allografts undergoing acute rejection. Transplant Proc XVII, No 1 (February), 618-622, 1985.
15. Beschorner WE.: Localization of the cellular components of acute rejection. In: Burdick JF., Racusen LC., Solez K & Williams GM (Eds.): Kidney Transplant Rejection. Diagnosis and treatment. Second Edition. Marchel Decker INC. New York, Basel & Hong Kong, 1992, pp. 393-417.
16. Bilitsky P & Gupta R. Fineneedle aspiration biopsy. In: Kidney Transplant Rejection. Diagnosis and treatment. Second edition. Brudick JF, Racusen LC, Solez K & Williams GM (eds). Marcel Decker, Inc. New York, Basel, Hong Kong 1992.
17. Bishop AG.Waugh J, Harvath JS, Johnson JR, Hall BM, Philips J, Duggin GG, Sheil AGR & Tiller DJ. Diagnosis of renal allograft rejection by analysis of fineneedle aspiration biopsy specimens with immunos-tains and simple cytology. The Lancet. Saturday 20 September: 645-649, 1986.
18. Bishop GA & Hall BM. Expression of leucocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int 1989; 36:1078-1085.
19. Bishop GA, Hall BM, Duggin GG, Horvath JS, Ross Sheil AG & Tiller DJ. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclearcell markers. Kid. Int. 29:708-717,1986.
20. Bishop GA, Waugh JA, Landers DV, Krensky AN & Hall BM. Microvascular destruction in renal transplant rejection. Transplantation 48:408-414,1989.
21. 2 in cocultures of lymphocytes and human tubular cells. J. Clin. Lab. Immunol. 31: 137-143,1990.
22. Blashr H, Andersen CB, Ladefoged J & Langhoff E. Human proximal tubular cells modulate allogen responses of leucocytes in vitro. APMIS 100: 832-838, 1992.
23. Bogman MJJT, van De Winkel DGJ, Hoitsma AJ, Ruiter DJ, Dooper IMM, Tax WJM, Assmann KJM & Koene RAR Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody,WT14. Lancet, July 29:235-238,1989.
24. Bohman SO,Wilczek H, Reinholdt FP, vonWillebarnd E & Häyry P. Immunopathological patterns in long-term renal allografts. Transplantation 51:610-613,1991.
25. Borel JF, Feurer C, Gubler HU & Stahelin H. Biological effects of cyclosporin A: A new antilymphocytic agent. Agent Act 6:468,1976.
26. Borel JF. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunol 31:631, 1976.
27. Boyce NW, Hayes K, Gee D, Holdsworth SR, Thomson NM, Scott D & Atkins RC. Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy. Transplantation 1988; 45:706-709.
28. Boyd AW, Wawryk SO, Burns GF et al. Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contract-mediated immune mechanisms. Proc Natl Acad Sci (USA) 1988; 85:3095-3099.
29. Bradley JR. Role of endothelial cells in immune response. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 58-73.
30. Brubaker DB. Transfusion-associated graft-versus-host disease. Human Pathol 17:1085,1986.
31. Brun C & OlsenTH. Pathology of the renal allograft. In: Brunc C & OlsenTH (eds.): Atlas of renal biopsies. Munksgård, Copenhagen, 1981, pp. 200-241.
32. Burdick J.F., Beschorner W.E., SmithW.J., McGraw D., Bender WL, Williams G.M. & Solez K.: Characteristics of early routine renal allograft biopsies.Transplantation 38:679-684,1984.
33. Burdick JF, Vogelsang GB, SmithWJ, Bias WB, Kaufmann SH, Horn J, Colombani PM, Pitt HA, Perler BA, Merritt WT, Williams GM, Boitnott JK, Herlog HE Severe graft-versus-host disease in a liver-transplant recipient. New Eng J Med 318:689,1988.
34. Burns J, Chan VTW, Jonasson JA, Flemming KA,Taylor S & McGee JO'D. Sensitive system for visualizing biotinylated DNA probes hybridized in situ: Rapid sex determination of intact cells. J Clin Pathol 38: 1085, 1985.
35. Burns J, Redfern DRM, Esiri MM & and McGee J.O'D. Human and viral gene detection in routine paraffin embedded tissue by in situ hybridization with biotinylated probes: Viral localization in herpes encephalitis. J clin Pathol 39:1066-1073,1986.
36. Carpenter CB, d'Apice AJF & Abbas AK. The role of antibodies in the rejection and enhancement of organ allografts. Adv Immunol 1976:22-1-55.
37. Cerilli J, Holliday JE,Wilson CB & Sharma HM: Clinical significance of the 1-hour biopsy in renal transplantation. Transplantation 26:91-93,1978.
38. Chen RH & Fuggle SV. In situ cDNA polymerase chain reaction. A novel technique for detecting mRNA expression. Am J Pathol 43:1527-1534,1993.
39. 8. Eur J Immunol 22:805-810,1992.
40. Chrysostomou A,Walker RG, Russ GR, D'Apice AJF, Kincaid-Smith P & Mathew TH. Diltiazem in renal allograft recipients receiving cyclosporone. Transplantation 55:300-304,1993.
41. Claesson K. Mechanisms in organ allograft rejection. An experimental and clinical study. (Dissertation). Scand J Urol Nephrol suppl 103,42 p, 1987.
42. Clark KR, Forsythe JLR, Shanton BK, Lennard TWJ, Proud G & Taylor RMR. Administration of ATG according to the absolute T lymphocyte-count during therapy for steroid-resistant rejection. Transplant Int 6: 18-21; 1993.
43. Cohen DJ, Loertscher R, Rubin M.Tilney NL, Carpenter CB & Strom TB. Cyclosporin: A new immunosuppressive agent for organ transplantation. Ann Int Med 101:667-678,1984.
44. Colvin RB, Prefier FI, Fuller TC, Brown MC, Ip SH, Kung PC & Cosimi AB. A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients. Transplantation 48:800-805,1989.
45. Colvin RB. Clinical application of monoclonal antibodies in renal allograft biopsies. Am J Kidn Dis 2:126-130,1988.
46. Cooke HJ, Schmidtke J & Gosden JR. Characterisation of a human Ychromosome repeated sequence and related sequences in higher primates. Chromosoma 87: 491-502,1982.
47. Cordell JL, Falini B, Erber WN, Chosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H & Mason DY Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase. J Histochem Cytochem 32:219-229,1984.
48. Cosimi AB, Conti D, Delmonico FL, Prefier FI, Wee SL, Rothlein R, Faames R & Colvin RB. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in non-human primates with renal allografts. J Immunol 144: 4604-4612,1990.
49. Cotran RS. New roles for the endothelium in inflammation and immunity. Am. J. Pathol. 129:407-413,1987.
50. Curschellas E, Landmann J, Dürig M, Huser B, Kyo M, Basler V, Thiel G & Mihatsch MJ: Morphologic findings in"zero-hour" biopsies of renal transplants. Clinical Nephrol. 36:215-22,1991.
51. d'Ardenne AJ, Dunnill MS,Thompson JF, McWhinnie D.Wood RFM & Moris PJ. Cyclosporin and renal graft histology. J Clin Pathol 39:145-151,1986.
52. Defelippi P, Silengo L & Tarone G. Regulation of adhesion receptors expression in endothelial cells. In: Dunon D, Mackay CR & Imhof BA (eds). Adhesion in leucocyte homing and differentiation. Springer Verlag. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona & Budapest. 1993, pp. 87-96.
53. Dieperink H, Leyssac JP, Starklint H & Kemp E. Nephrotoxicity of cyclosporin A. A lithium clearance and micropuncture study in rats. Eur J Clin Invest 16: 69-77,1986.
54. Dudd MA & Britten KJM. Tissue preparation for the demonstration of surface antigens by immunoperoxidase techniques. Histochem J 14:747-753,1982.
55. Daar AS, Fuggle SV, Fabre J W,Ting A & Morris PJ. The detailed distribution of MHC class II antigen in normal human organs. Transplantation 38:293-298,1984.
56. Ehrich JHH, Oeerlings W, Jones EHP, Landais P, Loirat C, Mallick NP, Margreiter R, Raine AEG, Saker LS, Salmela K, Selwood NH.Tufveson G & Valderrabano F. In: Figures from annual report on management of renal failure in Europe, XXIII, 1992; pp. 28-30. Presented at the XX congress of European Renal Association -The European Dialysis and Transplant Association, Glasgow 1993.
57. Farnsworth A, Hall B, BPNg A, Duggin GG, Hervates JS, Sheil AGR & Tiller DJ. Renal biopsy morphology in renal transplantation. Am J Surg Pathol. 8: 243-252, 1984.
58. Faull RJ & Russ GR.Very late antigen molecules in renal allografts. Transplantation Proc. 23:114-116,1991.
59. Faull RJ & Russ GR. Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection. Transplantation 48:226-230,1989.
60. Fontes P, Rao AS, Denmetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Rudert WA, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elmagd K, Jordan M, Fung JJ & Starzl TE. Bone marrow augmentation of doror-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. The Lancet 344:151-155, 1994
61. Fryd DS, Peterson PK, Ferguson RM, Simmons RL, Balfour HH & Najarian JS. Cytomegalovirus as a risk factor in renal transplantation. Transplantation 30: 436-439,1980.
62. Fuggle SV, Errasti P, Daar AS, Fabre JW.Ting A & Morris PJ. Localization of major histocompatibility com-plex (HLA-ABC and DR) antigens in 46 kidneys. Transplantation 35:385-390,1983.
63. Fuggle SV, McWhinnie DL & Chapman J. Sequential analysis of HLA class II antigen expression in human renal allografts. Induction of tubular class II antigen expression and correlation with clinical parameters. Transplantation 1986; 42:144-150.
64. Fuggle SV, Sanderson JB, Gray DWR, Richardson A & Morris PJ.Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys - correlation with intragraft events. Transplantation 55:117-123,1993.
65. Gonzales-Posada JM, Carera Castro C, Losada M, Lorenzo V,Torres A, Hernandez D, Maccita B & Salido E. Monoclonal analysis of fine-needle aspiration biopsy in kidney allografts. Nephrol Dial Transplant 5:226-231,1990.
66. Gorer PA, Lyman S & Snell GD. Studies on the genetic and antigenic basis of tumor transplantation; linkage between a histocompatibility gene and "fused" in mice. Proc R Soc Lond 135:499; 1948.
67. Greber N, Gopal TV,Wilson D, Dawson Beall LD, Polte T & Newmann W.T cell bind to cytokine-activated cells via a novel, inducible sialoglycoprotein and endothelial leucocyte adhesion molecule-1. J Immunol 145:819-830, 1990.
68. Gruber SA. The case for local immunosuppression. Transplantation 54:1-11,1992.
69. 3. Clin Transplantation 5:219-232,1991.
70. Guerin C, Pozzetto B, Genin C, Berthoux FC & Gaudin OG. Incidence of cytomegalovirus infections in renal transplant recipients treated with conventional or cyclosporin therapy. Nephrol Dial Transplant 3: 77-80, 1988.
71. Gundersen HJG, Bagger P. Bendtzen TF, Evans SM, Korbo L, Marcussen N, Møller A, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A & West MJ. The new sterological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96: 857-881, 1988.
72. Hameed A, Olsen KJ, Chang L, Fox WM, Hruben RH & Podack ER. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 140:1025-1030,1992.
73. Hamilton D: Kidney Transplantation: A history. In: Morris PJ (ed): Kidney Transplantation, 2nd ed, pp 1-13. Orlando, Grune & Stratton, 1984.
74. Hancock WW, Gee D, De Moerloose P, Rickles FR, Ewan VA & Atkins RC. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Transplantation 39:430-438,1985.
75. Hancock WW, Thomson NM & Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 35:458-463,1983.
76. Hang CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkoff-Rubin NT, Prefier FI, Rothlein R, Norris S, Scharschmidt L & Cosimi AB. A phase I trial ofimmunosuppression anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-773,1993.
77. Heberman R. Immunoregulation and natural killer cells. Mol Immunol 19:1313-1321,1982.
78. Helderman JH, Hernandez J, Sagalowsky A, Dawidson I, Glennie J,Wemble D,Toto RD, Brinker K & Hull AR. Confirmation of the utility of the fine needle aspiration biopsy of the renal allograft. Kid Int 34: 376-381,1988.
79. Herbertson BM, Evans DB, Calne RY & Banerjee AK. Percutaneous needle biopsies of renal allografts: The relationship between morphological changes present in biopsies and subsequent function. Histopathol 1:161-178,1977.
80. Hermann GG. The LAK cytotoxicity in vivo. In: Hermann GG. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma (Dissertation), Munksgaard. Copenhagen 1993, pp.13-19.
81. Herrington S & O'D McGea I Principles and basic methodology of DNA/RNA detection by in situ hybridization. In: Herrington GS & McGee J'OD (eds). Diagnostic molecular pathology. A practical approach. IRL Press. Oxford, New York, Tokyo. 1992, pp. 69-102.
82. Heryet AR & Gatter KC. Immunohistochemistry for light microscopy. In: Herrington GS & McGee J'OD (eds). Diagnostic molecular pathology. A practical approach. IRL Press. Oxford, New York, Tokyo. 1992, pp. 7-46.
83. Hogg N. A model of leucocyte adhesion to vascular endothelium. In: Dunon D, Mackay CR & Imhof BA (eds). Adhesion in leucocyte homing and differentiation. Springer Verlag. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona & Budapest. 1993, pp. 79-86.
84. Hsu AC, Arbus GS, Noriega E & Huber J. Renal allograft biopsy: A satisfactory adjunct for predicting renal function after graft rejection. Clin Nephrol 5:260-265, 1976.
85. Hume DM, Merrill JP, Miller BE & Thorn GW Esperiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest 34:327-382,1955.
86. Hunt BJ,Yacoub M, Amin S, Devenish A & Contrereas M. Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation. Transplantation 46:246-249, 1988.
87. Hutchinsom IV. Effector mechanisms in transplant rejection - an overview. In: Rose ML & Yacoub M (eds). Immunology of heart and lung transplantation. Arnold E. London, Boston, Melburne & Auckland. 1993: pp. 13-14.
88. Häyry P & von Willebrand E. Monitoring of human renal allograft rejection with fine-needle aspiration cytology. Scand J Immunol 13:87-97; 1981.
89. Häyry P & von Willebrand E. Practical guidelines for fine needle aspiration biopsy of human renal allografts. Annals of Clinical Research 13:288-306,1981.
90. Häyry P, von willebrand E & Soots A. In situ effector mechanisms in rat kidney allograft rejection. III. Kinetics of the inflammatory response and generation of donor-directed killer cells. Scand J Immunol 10: 95-108,1979.
91. Häyry P, von Willebrand E, Parthenais E, Nemlander A, Soots A, Lautenschlager I, Alfoldy P & Rekonen R. The inflammatory mechanisms of allograft rejection. Immunological Rev 77:85-142,1984.
92. Häyry P. Fine-needle aspiration biopsy in renal transplantation. Kid Int 36:130-141,1989.
93. Häyry P. Intragraft events in allograft distruction. Transplantation 38:1-6,1984.
94. Inghirami G, Ying Zhu B, Chess L & Knowles DM. Flovv-cytometric and immunohistochemical characterization of the γ/δ T-lymphocyte population in the normal human lymphoid tissue and peripheral blood. Am J Pathol 136:357-367,1990.
95. Inverardi L, Socu C & Pardi R. Leucocyte adhesion in graft recognition and rejection. Xeno 1:35-39,1993.
96. Ishikura H.Takahashi C, Kanagawa K, Hirata H, Imai K & Yoshiki T. Cytokine regulation of ICAM-1 expression on human renal tubular cells in vitro.Transplantation 51:1272-1275,1991.
97. Isobe M,Yagita H, Okumura K & Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255: 1125-1127, 1992.
98. Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W.Wuthrich RP, Glimcher LH & Kelley VE. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNFα. Kid Int 40: 203-211,1991.
99. Jevnikar AM,Wuthrich RP,Takei F et al. Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kid Int 38:417-425,1990.
100. Jiwa NM, van Gemert GW, Raap AK, van de Rijke FM, Mulder A, Lens PF, Salimans MMM, Zwaan FE, Dorp WV & van der Ploeg M. Rapid detection of human cytomegalovirus DNA in peripheral blood leucocytes of viremic transplant receipients by the polymerase chain reaction. Transplantation 48:72-76,1989.
101. Jordan ML. Immunosuppressive therapy and results of renal transplantation. Current opinion in Urology 3: 126-132,1993.
102. Jutila MA. Leucocyte traffic to sites of inflammation. APMIS 100:191-201,1992.
103. 3. Transplant Proc 21:3594-3595,1980.
104. Jorgensen KA, Strate M, SvendsenV, Rohr N, Elbirk A & Birkeland S. Are FNAB correction factors correct. Transplant Proc. 21:3603-3604,1989.
105. Kemp E. Nefrologi og Transplantation. In: Siboni K (ed): Lægevidenskab ved Odense Universitet, capter 15, p. 267, Odense Universitet Forlag 1991.
106. 3 therapy on infiltrating lymphocytes in rejecting renal allografts. Transplantation 48:33-36,1989.
107. Kincaid-Smith P, Morris PJ, Saker BM,Ting A & Mar-shall VC. Intermediate renal-graft biopsy and subsequent rejection. Lancet: October 5,748-749,1968.
108. Kirby JA, Rajasekar MR, Lin Y, Pround G & Taylor RMJ. Interaction between T lymphocytes and kidney epithelial cells during allograft rejection. Kid. Int. Suppl. 39: pp. S124-S128,1993.
109. Kirk AD, Ibrahim MA, Bollinger RR, Dawson DV & Finn OJ. Renal allograft-infiltrating lymphocytes. Transplantation 53:329-338,1992.
110. Kishimoto TK,Warnock RA, Jutila MA, Butcher EC, Lane C, Anderson D & Wayne Smith C. Antibodies against human neutrophil LICAM-1 (LAM-1/Leu8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro. Blood 78:805-811,1991.
111. Kissmeyer-Nielsen F, Olsen S, Petersen KP & Fjeldborg O. Hyperacute rejection of kidney allografts associated with preexisting humoral antibodies against donor cells. Lancet 2:662; 1966.
112. Kiær H, Hansen HE & Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 13: No 2; 58-63,1980.
113. Klein J. In Immunology: The science of self-non self discrimination. New York: John Wiley and Sons, 1982; 20-31,277-85.
114. Klintmalm G, Bergstrand A, Ringdén O,Wasserman J, Collste H, Lundgren G,Wilczek H, Groth CH. Graft biopsy for the differentiation between nephrotoxicity and rejection in cyclosporin-A-treated renal transplanted recipients. Transplant Proc 14:493-496,1983.
115. Knobloch C, Goldmann SF, Lattke H, Friedrich W Stable engraftment of allogeneicT-lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood.Transplantation 51.818,1991.
116. Kolbeck P.C., Tatum A.H. & Sanfilippo F.: Relationships among the histologic pattern, intensity, and phenotypes of T cells infiltrating renal allografts. Transplantation 38:709-713,1984.
117. Komminoth P & Long AA. In-situ polymerase chain reaction. An overview of methods, applications and limitations of new molecular technique. Virch Arch B Cell Pathol 64:67-73,1993.
118. Kormendi F & Amend Jr WJC. The importance of eosinophil cells in kidney allograft rejection. Kid Int 45: 537-539,1988.
119. Koyama H & Ceeka JM. Rejection episodes. In:Terasaki PL & Ceeka JM (eds). Clinical Transplants 1992, UCLA Tissue Typing Laboratory, Los Angeles, California pp. 391-404.
120. Ladefoged S & Andersen CB. Calcium channel blockers in kidney transplantation. Clin Transplantation 8: 128-133,1994.
121. Ladefoged SD, Pedersen E., Hammer M., Rasmussen KC. & Andersen CB.: Clinical effects of diltiazem in renal transplantation. A prospective, double-blind, placebo-controlled study. Nephr Dial Transplant 9: 534-537,1994.
122. Lanier LL, Le AM, Philips JH,Warner NL & Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu 7 (HNK-1) and Leu 11 (NK15) antigens. J Immunol 131:1789-1796,1983.
123. Larsen S, Brun C, Duun S, Lokkegaard H & Thomsen HS. Early arteriolopathy following "high-dose" cyclosporine in kidney transplantation. APMIS suppl. 4: 66-73,1988.
124. Larsen S. Immunohistochemical Investigation of kidney tissue. In: Larsen S. Immune deposits in human glomerulopathy. Dissertation pp. 38-46, Copenhagen 1981.
125. Larsson L-I. Immuncotochemical detection symptoms. In: Immunocytochemistry. Theory and practice. 2nd ed. CRC Press. USA. 1989, pp. 41-76 & pp. 77-146.
126. Larsson L-I. Antibodies and antisera. In: Immunocytochemistry. Theory and practice. 2nd ed. CRC Press. USA. 1989, pp. 1-40.
127. Larsson L-I. Different interpretations of immunocytochemical specificity. In: Immunocytochemistry. Theory and practice. 2nd ed. CRC Press. USA. 1989, pp. 193-195.
128. Larsson L-I. Different interpretations of immunocytochemical specificity. In: Immunocytochemistry. Theory and practice. 2nd ed. CRC Press. USA. 1989, pp. 19-20.
129. Larsson L-I. Fixation and tissue pretreatment (chapter 2). Section pretreatment, Epitope demasking, and methods for dealing with unwanted staining. In: immunocytochemistry. Theory and practice. 2nd ed. CRC Press. USA. 1989, pp. 41-76 & pp. 147-170.
130. Larsson L-I. In situ hybridization of messenger RNA sequences. Histochemical Journal 21:435-440,1981.
131. Lisby G, Dessau R, Andersen CB & Ladefoged S. Polymerase chain reaction as a rapid diagnostic assay for cytomegalovirus infection in renal transplant patients. APMIS 102:690-694,1994
132. Lovett DH, Resch K & Gemsa D. Interleukin I and the glomerular mesangium. II. Monokine Simulation of mesangial cell prostanoid secretion. Am J Pathol 129: 543-551:1987.
133. Lowry RP & Takenuchi T. Immunologic tolerance and its relationship to clinical transplantation. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 90-92.
134. Lowry RP & Takenuchi T. Immunologic tolerance and its relationship to clinical transplantation. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 174-179.
135. Lowry RP & Takenuchi T. Immunologic tolerance and its relationship to clinical transplantation. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 105-107 & 115-117.
136. Makgoba MW, Sanders ME, Luce GEG, Gugel EA, Dustin ML, Springer TA & Shaw S. Functional evi-dence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T-cell mediated cytotoxicity. Eur J Immunol 18:637-646,1988.
137. Male D & Roth I. Introduction to the immune system. In: Roth I, Brostoff J & Male D (eds.). Immunology. Third edition, Mosby, St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto. 1993, pp. 1.7.
138. Mandreoli M, Esroshi ED, Cocchi R, Fabbri A, Gucrini L & Fasaroli M. Do calcium channel blockers have any influence on the immunological status of renal graft recipients on cyclosporin therapy. Am J Nephrol 10:58-60,1990.
139. Markovic-Lipkowski J, Müller CA, Engler-Blum G, Strutz F, Kühn W, Risler T, Lanchart W & Müller GA. Human cytomegalovirus in rejected kidney grafts; detection by polymerase chain reaction. Nephrol Dial Transplant 7:865-870,1992.
140. Maryniak RK, Roy First M & Weis MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kid Int 27:799-806,1985.
141. Mason DY & Gatter KG The role of immunohistochemistry in diagnostic pathology. J Clin Pathol 40: 1042-1054,1987.
142. Matas AJ, Sibley R, Mauer SM, Kim Y, Sutherland DER, Simmons RL & Najarian JS. Pre-discharge, post-transplant kidney biopsy does not predict rejection. J Surg Research 32:264-274,1982.
143. Mayer TG, Fuller A, Fuller TC, Lazarovits AI, Boyk LA & Kurnick JT. Characterization of in vivo-activated allospecificT-lymphocytes propagated from human renal allograft biopsies undergoing rejection. The Journal of Immunology 134,258-264,1985.
144. McWhinnie DL, Thompson JF, Taylor HM, Chapman JR, Bolton EM, Carter NP,Wood RFM & Morris PJ: Morphometric analysis of cellular infiltration assessed by monoclonal antibody labelling in sequential human renal allograft biopsies. Transplantation 42: 352-358, 1986.
145. Miceli C, Metzgar S, Chedid M,Ward F & Finn OJ. Long-term culture and characterization of alloreactive T-cells infiltrates from renal needle biopsies. Human Immunol 14:295-304,1985.
146. Michael Olive D, Al Mufti S, Sinsek M, Fayez H & Al Nacib W. Direct detection of human cytomegalovirus in urine specimens from renal transplant patients following polymerase chain amplification. J Med Virol 29:232-237,1989.
147. Mihatsch MJ, Bach JF, Coovadia HM, Førre Ø, Moutsopoulos HM, Drosos AA, Siamopoulos KC, Noel LH, Ramsaroop R, Hällgren R, Svenson K & Bohma SO. Cyclosporin-associated nephropathy in patients with autoimmune diseases. Klin Wschr 66:43-47,1988.
148. Mihatsch MJ,Thiel G, Sphichtin HP, Oberholzer M, Brunner FP, Harder F, Olivieri V, Bremer R, Ryffel B, Stocklin E, Torhorst J, Gudat F, Zollinger HU & Loertscher R. Morphological findings in kidney transplant after treatment with cyclosporine. Transplant Proc 15 (4: suppl. 1): 2821-2835,1983.
149. Miller SM, Bilitsky P & Gupta R. Fine-needle aspira-tion biopsy sampling in renal transplantation: Interstitial cellular infiltrates and major histocompatibility complex class-II antigen expression in renal tubular cells. Urol Int 44:346-351,1989.
150. Morris PJ. Cyclosporin A. Transplantation 32:349; 1981.
151. Murray JE, Merril JP, Dammin GC, Dealy JB, Walter CW, Brooke MS & Wilson RE. Study on transplantation immunity after total body irradiation: Clinical and experimental investigation. Surgery 48: 278-284, 1960.
152. Murray JE, Merrill JP & Harrison JH. Kidney transplantation between seven pairs of indentical twins. Ann Surg 148:343; 1958.
153. Nadasdy T, Krenacs T, Kalmar KN, Csajbok E, Boda K & Ormos I Importance of plasma cells in the infiltration of renal allografts. Path Res Pract 187:178-183,1991.
154. Neilson EG & Zakheim B. T cell regulation, anti-idiotypic immunity, and the nephritogenic immune response. Kid Int 24:289-302,1983.
155. Nemlander A, Soots A & Hayry P. Redistribution of renal allograft responding leucocytes during rejection. J Exp Med 256:1087-1100,1982.
156. Niaudet P, Raguin G, Le Fevre JJ, Busson M, Caban N, Fortier B, Bone A, Broyer M, Bedrossian J, Fries D, Kreis H & Sraer S-D... Serological status of cytomegalovirus and outcome of renal transplantation. Kid Int 23: S-50-S-53,1983.
157. Noronna IC, Eberlein-Ganska M, Hartleu B, Spehens S, Caeron JS & Waldherr R. In situ expression of tumor necrosis factor-alpha, interfern-gamma, and interleukin-2 receptors in renal allograft biopsies.Transplantation 54:1017-1024,1992.
158. Olsen ST.: Pathology of allograft rejection. In: Burdick JE, Racusen L.C., Solez K. & Williams G.M. (Eds.): Kidney Transplant Rejection. Diagnosis and treatment. Second Edition. Marchel Decker INC. New York, Basel & Hong Kong, 1992, pp. 333-357.
159. Orosz CG,Ohye RG, Pelletier RP, van Buskirk AMV, Huang E, Morgan C, Kincade PW & Ferguson RM. Treatment with anti-vascular cell adhesion molecule-1 monoclonal antibody induces long-term murine cardiac allograft ecceptanse. Transplantation 56: 453-460, 1993.
160. Palestine AG, Austin HA, Balow JE, Antonovych TT, Sabnis SG, Preuss HG & Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. New Eng J Med 314:1293-1297,1986.
161. Palmer BF, Davidson I, Sagalowsky A, Sandor Z & Y Lu C. Improved outcome of cadaver renal transplantation due to calcium chanal blocker. Transplantation 52:640-645,1991.
162. Pardi R, Inverardi L & Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travellers. Immunol. Today 13: 224-230, 1992.
163. Parfrey NA. Cytokines-regulators and effectors of immune responses. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp 61-71.
164. Pastenak MS. Cytotoxic T lymphocytes. Adv Intern Med 33:17-44,1988.
165. Paul LC, Grothman GT, Benedictsson H, Davidhoff A & Rozing D. Machrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation 53:157-162,1992.
166. Pepinsky B, Hession C, Chen LL, May P, Burkley L, Jakubowski A, Chow EP, Benjamin C, Chi-Ross GG, Lubowsky S & Lobb R. Structure/function studies on vascular cell adhesion molecule-1. J Biol Chem 267:17820-17826,1992.
167. Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ & Simmons RL. Cytomegalovirus disease in renal allograft recipients: A prospective study of clinical features, risk factors and impact on renal transplantation. Medicine 59:283-300,1980.
168. Platt JL & Bach FH. The barrier to xenotransplantation. Transplantation 52; 937-947,1991.
169. Platt JL, Ferguson RM, Sibley RK, Gajl-Peczalska KJ & Michael AF. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies. Transplantation 36:343-345,1983.
170. Poulsen JV, Rasmussen A, Hansen HE, Fjeldborg O, Kissmeyer-Nielsen F, Madsen M. Acquired haemolytic anaemia due to isohaemagglutinins of donor origin following ABO-minor-incompatible kidney transplantation. Nephrol Dial Transplant 5:148,1990.
171. Pringle JH, Homer CE.Warford A, Kendall CH & Lauder I. In situ hybridization: Alkaline phosphatiase visualization of bioptinylated probes in cryostat and paraffin sections. Histochem J 19:488-496,1987.
172. Rao VK., Kasiske BL, Odlund MD, Ney AL & Andersen RC: Influence of cadaver donor age on posttransplant renal function and graft outcome. Transplantation 49:91-95,1990.
173. Reinholdt FP, Bohman SO,Wilczek H, von Willebrand E & Häyry P. Fine-needle aspiration cytology and conventional histology in 200 renal biopsies. Transplantation 49:910-912,1990.
174. Reitz BA, Bieber CP, Raney AA, Pennock JL, Jamieson SW, Oyer PE & Stinson EB. Orthotopic heart and combined heart and lung transplantation with cyclosporin A immune suppression. Transplant Proc 13:393; 1981.
175. Riehl J, Maigatter S, Kierdorf H, Schmitt H, Maurin N & Sieberth HG. Percutaneus renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys. Nephrol Dial Transplant 9:1568-1574; 1994.
176. Roitt I, Brostoff J & Male D. Transplantation and rejection. In: Immunology (3 ed) pp. 23.1-23.14, Mosby: St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto, 1993.
177. Rook G. Cell-mediated immune reactions. In: Roth I, Brostoff J & Male D (eds.). Immunology. Third edition, Mosby, St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto. 1993, pp. 8.2-8.4.
178. Rook G. The cytokine network. In: Roth I, Brostoff J & Male D (eds.). Immunology. Third edition, Mosby, St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto. 1993, pp. 8.12-8.15.
179. Rubin RH & Colvin RB. Cytomegalovirus infection in renal transplantation. Clinical importance and control. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 675-696.
180. Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, Beth RF, Hillis W, Szinuness W, Farret ML & Hirsch MS. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243-249.
181. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Reviews of infectious diseases 12, Suppl 7: S754-S766,1990.
182. 3 in vascular rejection. Transplantation 51:312-315,1991.
183. Scopi L & Larsson L-I. Increased sensitivity of a number of peroxidase visualization methods employing a model system. Histochemistry 84:2221-2230,1986.
184. Sedmak DD, Roberts WH, Stephens RE, Buesching WJ, Morgan LA, Davis DH & Waldman WJ. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigens expression. Transplantation 49: 458-462,1990.
185. Sekum CM, Hegre OD, Serie JR, Moore WV. The potency of splenic dendritic cells as allogen presenters in vivo: Quantiation of the number of cell requested to achieve graft rejection. Transplantation 49: 1175-1177, 1990.
186. Shaff D, Abrahams C & Meyers A: A detailed analysis of the 1. hour posttransplant renal biopsy. Nephron. 24: 25-29,1979.
187. Singer RH, Lawrence JB & Villnave C Optimization of in situ hybridization using isotopic and non-isotopic detection methods. Bio Feature 3:230-250,1986.
188. Smith KA. T-cell growth factor. Immunol Rev 51: 337, 1980.
189. Solez K, Axelsen RA, Hallgrimur B, Burdick JF, Cohen AH, Colvin RB, Croker BP, Dominique D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LR, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, von Willebrand E & Yamaguchi Y. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kid Int 44:411-422,1993.
190. Solez K, Marcussen N & Flynn G. Pathology of acute tubular necrosis and acute rejection. Observations on early systematic renal transplant biopsis. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 373-392.
191. Solez K, Racusen LC, Marcussen N, Slatnik I, Keown P, Burdick JF & Olsen S. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney International 43:1058-1067,1993.
192. Spencer ES & Jepsen FL. Glomerulopathy in renal allografts from patients with and without active cytomegalovirus infection. Danish Medical Bulletin 36: 299-301,1989.
193. Spencer ES, Fjeldborg O & Kerzel Andersen H. Cytomegalovirus infection and kidney graft survival. Scand J Urol Nephrol, Suppl 64:128-131,1981.
194. Springer TA. Adhesion receptors of the immune system. Nature 346:426-434,1990.
195. Startzl TE, Marchioro TL & Waddell WR. The reversal of rejection in human renal homograft with subsequent development of homograft tolerance. Surg Gynecol Obstet 117:385-395,1963.
196. 4 and anti-interleukin-2 receptor monoclonal antibodies. APMIS100:682-694,1992.
197. Sternberger LA. Specificity. In: Stemberger LA (ed.): Immunocytochemistry. 2nd ed. John Wiley & Sons. New York, Chichester, Brisbane & Toronto. 1982, pp. 95-96.
198. Stemberger LA. Specificity. In: Sternberger LA (ed.): Immunocytochemistry. 2nd ed. John Wiley & Sons. New York, Chichester, Brisbane & Toronto. 1982, pp. 93-95.
199. Suberbielle C, Caillat-Zucman S, Legendre C, Bodemer C, Noel L-H, Kreis H & Bach J-F. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. The Lancet 343:1468-1469,1994.
200. Suranyi MG, Bishop A, Clayberger C, Krensky AM, Lecnarts P, Aversa G & Hall BM. Lymphocyte adhesion molecules in T-cell mediateded lysis of human kidney cells. Kid Int 39:312-319,1991.
201. Svanholm H, Starklint H, Gundersen HJG, Fabricius J, Barlebo H & Olsen S. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 97:689-698,1989.
202. Syrjänen SM. The sensitivity of in situ hybridization In: Herrington GS & McGee J'OD (eds). Diagnostic molecular pathology. A practical approach. IRL Press. Oxford, New York, Tokyo. 1992, pp. 131-132.
203. Taube DH, Williams DG, Hartley B, Rudge CJ, Neiled GH, Cameron JS, Ogg CS & Welsh KI. Differentiation between allograft rejection and cyclosporine nephrotoxicity in renal-transplant recipients. Lancet ii: 171175,1985.
204. Taylor PM, Rose ML, Yacoub M & Pigott R. Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation 54: 451-457, 1992.
205. Terasaki PI & Cecka JM. Rejection episodes. In:Terasaki PI & Cecka JM. Clinical transplants. UCLA Tissue Typing Laboratory. Los Angeles, California 1992: pp. 391-404.
206. Teresaki PI, MarchioroTL & Startzl TE. In: Histocompatibility testing, pp 83-95. National Academy of Sciences,Washington DC, 1965.
207. Thomas J.M., Thomas F.T., Emara M. & Verbanac X.: Acute rejection. In: Burdick J.F., Racusen L.C., Solez K. & Williams G.M. (Eds.): Kidney Transplant Rejection. Diagnosis and treatment. Second Edition. Marchel Decker INC. New York, Basel & Hong Kong, 1992, pp. 25-27.
208. Thomas JM, Thomas FT, Emara M & Verbanac K. Mechanisms of cell-mediated rejection. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 30-32.
209. Tilney NL, Kupiec-Weglinski JW, Heidecke CD, Lear PA & Strom TB. Mechanisms of rejection and prolongation ofvascularized organ allografts. Immunological Rev 77:185-216,1983.
210. Tovey MG, Deglise-favre A & Schoevaert D. Differential in situ expression of cytokine genes in human renal transplantation. Kid Int 43, suppl 39: pp. S129-S132, 1993.
211. Transfusions and graft-versus-host disease. Lancet 1: 529,1989.
212. Tykocinski ML & Kaplan DR. Prospects for anti-rejection therapies based upon CDg-dependent immune regulation. Kid Int 43, suppl 39: S.120-S.123,1993.
213. Unanue ER. Antigen-presenting function of the macrophage. Ann Rev Immunol 2:395-428,1984.
214. Unauue ER & Allan PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 36:551-557,1987.
215. van Leeuwen. Specific immunocytochemical localization of neuropeptides: A utopian goal. In: Bullock GR & Petrusz P. Techniques in immunocytochemistry. Academic Press. London, Orlando, San Diego, New York, Toronto, Montreal, Sydney & Tokyo. 1982, pp. 283-298.
216. van Norden. Problems and solutions. In: Beesley (JE (ed). Immunocytochemistry. A practical apporoach. IRL Press. Oxford, New York,Tokyo. 1993, pp. 207-239.
217. Varsluish DJ,Ten Kate FJW,Wenting GJ & Weinar W Mononuclear cells infiltration kidney allografts in the absence of rejection. Transplant Int 1:205-208,1988.
218. Vogelsang GB. Transfusion-associated graft-versus-host disease in non immunocompromised host. Transfusion 30:101,1990.
219. von Willebrand E, Pettersson E, Ahonen J & Häyry P. CMV infection, Class II antigen expression and kidney allograft rejection. Transplant 1986;42:364-367.
220. von Willebrand E, Salmela K, Isoniemi H, Krogerus L, Taskinen E & Häyry P: Induction of HLA Class II antigen and interleukin 2 receptor expression in acute vas-cular rejection of human kidney allografts. Transplantation 53:1077-1081,1992.
221. Wakabayashi T & Onoda H. Interdigitatin reticulum cells in human renal grafts.Virch Arch A. Pathol Anat 418:105-110,1991.
222. Warford A. In situ hybridization: A new tool in pathology. Med Lab Sci 45:381-394,1988.
223. Watzke H, Kovarik J & Gasner H. A permissive effect of cyclosporin on the development of isohaemaglutenins of graft origin in ABO-mismatched organ transplantation. Nephrol Dial Transplant 3:89-90,1988.
224. Winchester JF, Gefland MC, Foegh ML, Helfrich GB & Schreiner GE. Early indictators of renal allograft rejection. Kid Int 23 (suppl 14): S34-S40,1983.
225. Winn HJ. Antibody-mediated rejection. In: Burdick JP, Racusen LC, Solec K & Williams GM (eds): Kidney Transplant Rejection. Diagnosis and treatment. Second Edition. Marcel Dekker INC. New York, Basel & Hong Kong, 1992, pp. 319-329.
226. Winn HJ. Antibody-mediated rejection. In: Beschorner WE, Racusen LC, Solez K & Williams GM (eds.). Kidney Transplant Rejection. Diagnosis and Treatment. Second edition, Marcel Dekker, Inc. New York, Basel & Hong Kong. 1992, pp. 319-332.
227. Wood GS & Warnke R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 29:1196-1204,1981.
228. Wuthrich RP, Glimcher LH, Yui MA, Jernikar AM, Dumas SE & Kelley VE. Generation of highly differentiated murine renal tubular epithelial cell lines: MHC class II regulation, antigen presentation and tumor necrosis factor production. Kidney Int 37:783-792,1990.
229. Wuthrich RP, Jenkins TA & Snyder T. Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells. Transplantation 55:172-177, 1993.
230. Yard BA, Kooymans-Conthino M, Reterink T, van der Eisen P, Pnape ME, Bruyn JA, van Es LA, Daha MR & van der Wonde FJ. Analysis of T cell lines from rejecting renal allografts. Kid. Int. Suppl. 39, vol. 43, pp. S133-S138,1993.
231. Yoshimura N, Oka T & Kahan B. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. Transplantation 51: 172-176,1991.
232. 3 treatment. Transplant Proc 22:1782,1990.
233. Zutter M. Gamma-delta T-cells in the immune response. Am J Clin Pathol, June: 761-762,1991.